This Investment Network is an initiative of The Virus Project a platform for those working on solutions to the COVID crisis. The Investment Network will invest in the most promising solutions.
Author: Brett Johnson
Global Overview of COVID-19 Testing. The Development of a Core Curriculum. The Virus Project commissioned a research report by BALSA a consulting enterprise operating from the Washington University in St. Louis. The report provides an overview of the scientific, regulatory and market issues for the COVID-19 testing in the United States. It is an exceptional resource for understanding the COVID testing marketplace. The report provides an over view of this new market that largely did not exist in January 2020 but could reach $20 billion in revenues in 2021. It would be the fastest market growth for a dead start…
For its full members The Virus Project provides these two reports. A $750 Value. Foundational knowledge of COVID. US Report. Provides an overview of the scientific, regulatory and market issues for the COVID-19 testing market in the US and Europe. This market did not exist in January 2020 but could reach $20 billion in revenues in 2021. Growth Model on the potential size of the market and the various market segments. It includes an analysis of the impact on public stocks by COVID-19 during spring of 2020. Summary of core testing technologies. Molecular (PCR) tests and Serology IgM, IgA, IgG…
If businesses are not open and kids not in school, we are losing the war against COVID. A war we could and should be winning. Science and technology can defeat this invader that is destroying the global economy and taking and shattering millions of lives. But we need to unleash the power of innovation and information. Instead we are holding it back. Winning is not complex and it is NOT just a vaccine. To rely primarily on vaccines is simply foolish and could be a big mistake. Vaccines should be pursued full force, but there is no certainty any will be effective…
DRAFT Addressing COVID-19 is the most significant work being done in the world today. Scientists and entrepreneurs are developing projects to help return the world to some level of normalcy. For impact investors this represents a terrific opportunity. The Virus Project is uniquely positioned to find and vet these opportunities. We have already made tremendous progress in the critical area of testing and strongly believe the development of a network of investors can begin to look at direct investments in bringing these critical technologies to the marketplace. The Altru Impact Investment Club – A group of accredited Investors who want to…
Mesa Biotech designs, develops, manufactures and commercializes next-generation molecular diagnostic tests, bringing the superior diagnostic performance of nucleic acid PCR amplification to the point-of-care. Mesa’s proprietary OSCAR technology is key to the patented and patent-pending diagnostic solutions. The technology offers the simplicity, convenience and procedural familiarity of traditional POC rapid immunoassays while providing the superior sensitivity and specificity of laboratory-based molecular testing. Mesa Biotech has developed a qualitative, visually read test utilizing polymerase chain reaction (PCR) technology to detect SARS-CoV-2, the virus responsible for COVID-19. Using throat and nasal swabs, results are available in 30 minutes, based on the principles…
Rapidtests.org is an example of how a group of concerned citizens can form to address a critical challenge, in this case the need for rapid tests for COVID-19. The group is attracting highly skilled and informed citizens from across the US who see the potential of an inexpensive fast self-test to change the direction of the COVID disaster that is destroying the global economy.
Sherlock Biosciences, launched March of 2019, is an early-stage venture whose focus is to “develop affordable, instrument-free diagnostic tests for use in oncology and infectious diseases, as well as in industrial and agricultural applications. SHERLOCK is an evolution of CRISPR technology, which others use to make precise edits in genetic code. SHERLOCK can detect the unique genetic fingerprints of virtually any DNA or RNA sequence in any organism or pathogen. Developed by our founders and licensed exclusively from the Broad Institute, SHERLOCK is a method for single molecule detection of nucleic acid targets and stands for Specific High Sensitivity Enzymatic Reporter…